Please assess the completion status of the following clinical trial:

Trial Title: CRF - Nociceptin Receptor Interactions

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Males or females between 18 and 40 years old~Exclusion Criteria:~* Current DSM-5 psychiatric disorders~* Binge drinking as defined in NIAAA criteria in the past month~* Recreational abuse of opiates, sedative-hypnotics, cocaine, amphetamines, MDMA, and PCP, as well as cannabis use~* Currently on any prescription medical or psychotropic medication;~* Current or past severe medical, endocrine, cardiovascular, immunological or neurological illnesses~* Currently pregnant or breast-feeding;~* History of radioactivity exposure via prior nuclear medicine studies or occupational exposure in past twelve months~* Metallic objects in the body that are contraindicated for MRI;~* First-degree relative with psychosis or mood disorders

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- [C-11]NOP-1A PET Scan conditions (Type: EXPERIMENTAL): Baseline condition and Post-hydrocortisone (1 mg/Kg, intravenous) condition

Based on this trial design, predict the completion outcome and termination type (if applicable).